美股市場個股詳情

TCRX TScan Therapeutics

添加自選

8.010
-0.660-7.61%

收盤價 05/08 16:00 (美東)

8.010
0.0000.00%

盤後 16:00 (美東)

4.23億總市值-5889市盈率TTM

TScan Therapeutics股票討論區

登錄發表評論

Jaguar8

04/19 22:36

$TScan Therapeutics(TCRX.US)$
NEWS
TScan Therapeutics Announces Closing of Upsized Public Offering

Trytosaveabit

04/17 04:25

Grrr

$TScan Therapeutics(TCRX.US)$ TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering

Trytosaveabit

04/17 04:02

Update

$TScan Therapeutics(TCRX.US)$ TScan Therapeutics Inc -Patients Identified Across All Six Tcr-T Cohorts in Solid Tumor Program With Dosing of First Three Expected in Early May

Trytosaveabit

03/06 20:14

Pretty nice!

$TScan Therapeutics(TCRX.US)$ TScan Therapeutics (NASDAQ:TCRX) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.29) by 27.59 percent. This is a 73.08 percent increase over losses of $(0.78) per share from the same period last year. The company reported quarterly sales of $7.21 million which beat the analyst consensus estimate of $3.34 million by 115.90 percent. This is a 132.91 percent increase over sales of $3.10 million the same period...